Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia

This publication has 31 references indexed in Scilit:

• Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1990
• HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.
  Circulation, 1989
• Lipoprotein Lp(a). A risk factor for myocardial infarction.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor
  Journal of Molecular Medicine, 1988
• APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE
  The Lancet, 1988
• Effect of an HMG-CoA Reductase Inhibitor, CS-514, on the Total Cholesterol and Lp (a) Lipoprotein Levels in Serum
  The Journal of Japan Atherosclerosis Society, 1987
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levels
  Atherosclerosis, 1986
• Lp(a) lipoprotein as a risk factor for myocardial infarction
  JAMA, 1986
• Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
  Circulation, 1986
• Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1983